340B COMES UP DURING SENATE HEARING Created by j.blackburn@americanhealthcare.com on 3/22/2016 5:16:09 PM
As we reported in the Drug Discount Monitor, the chairwoman of the Senate Special Committee on Aging grilled a Turing Pharmaceuticals executive during a March 17 hearing for instructing a subordinate to dispute 340B claims in order to boost company profits. Click here and here for video clips of Chairwoman Susan Collins' (R-Maine) strong defense of 340B. We thank Senator Collins for her leadership on the important issue of high drug prices
For more information, visit www.340bhealth.org
The comment feature is locked by administrator.